This $189,896 Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to develop and pilot test the "Patient Reported Outcome Measures to Individualize Treatment and Improve Retention" (RETAIN) program intervention package. The objective is to capture patient-reported outcome measures (PROMs) for opioid use disorder (OUD) treatment in federally-qualified health centers (FQHCs). The funding will support the following activities over the award period from July 2024 to June 2029:
- Describing contextual factors and identifying RETAIN program adaptations and ideal PROM characteristics for FQHC-based OUD treatment settings.
- Applying user-centered design strategies to refine the RETAIN program intervention package adaptations.
- Conducting a pilot randomized controlled trial to assess the RETAIN program's initial effectiveness, feasibility, and acceptability over a 6-month period.
The grant recipient is the University of Colorado-Denver, a major public research university that is a significant recipient of federal funding for medical research and clinical services. This project represents an effort to bridge the evidence-to-practice gap by implementing measurement-based care for OUD treatment in real-world primary care settings.
Generated 2/25/25, 3:21 AM